Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517276) titled 'TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index' on April 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Peking University First Hospital

Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development

Intervention: Drug: tauroursodeoxycholic acid (TUDCA)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 2, 2026

Targe...